Issue 4, 2026

Mechanistic insights into the cholesterol-lowering activity of γ-oryzanol components

Abstract

γ-Oryzanol, a mixture of phytosteryl ferulates present in rice bran, has gained attention for its cholesterol-lowering properties, likely due to its interaction with the pharmacological target enzyme 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR). Our study explores the individual contributions of the four major γ-oryzanol constituents, namely cycloartenyl ferulate, campesteryl ferulate, β-sitosteryl ferulate, and 24-methylenecycloartenyl ferulate, to cholesterol synthesis and efflux/excretion. First, according to a concerted approach involving molecular docking, surface plasmon resonance binding studies, and enzyme inhibition assays, we determined the binding affinities and inhibitory activities of each constituent toward HMGCR. Additionally, we evaluated their impact on cholesterol metabolism in HepG2 cells by assessing the cellular cholesterol levels and the expression of selected biomarkers of cholesterol metabolism pathways under non-cytotoxic conditions. The major components of γ-oryzanol, cycloartenyl ferulate (CAF) and 24-methylenecycloartenyl ferulate (24MCAF) significantly affected cholesterol metabolism and reduced cellular cholesterol levels via distinct mechanisms, despite their highly conserved chemical structures. Specifically, CAF reduced the total and free cholesterol levels, consequently triggering a compensatory activation of the SREBP-2 pathway, marked by increased HMGCR and LDL receptor expression, whereas 24MCAF moderately lowered cholesterol and enhanced its clearance primarily by upregulating the cholesterol efflux transporter ABCG1. Instead, both CAF and 24MCAF comparably affected ABCA1, another cholesterol efflux regulatory protein, and CYP7A1, essential for converting cholesterol into bile acids. Together, these dynamics reveal a dual modulation that supports the lipid-lowering effects of γ-oryzanol components and highlights their potential as therapeutic agents in cholesterol management.

Graphical abstract: Mechanistic insights into the cholesterol-lowering activity of γ-oryzanol components

Supplementary files

Article information

Article type
Paper
Submitted
10 Aug 2025
Accepted
15 Jan 2026
First published
21 Jan 2026
This article is Open Access
Creative Commons BY license

Food Funct., 2026,17, 1930-1940

Mechanistic insights into the cholesterol-lowering activity of γ-oryzanol components

M. Cuccioloni, H. Juricic, L. Bonfili, Z. Liu, G. Abate, D. Uberti, M. Angeletti, A. M. Eleuteri and V. Cecarini, Food Funct., 2026, 17, 1930 DOI: 10.1039/D5FO03394B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements